(Q36174517)

12 August 2017

1 reference

title

Cardiotoxicity of cancer chemotherapy: implications for children (English)

1 reference

12 August 2017

1 reference

5

Steven E Lipshultz

1 reference

12 August 2017

Valeriano C Simbre

1

1 reference

12 August 2017

Sarah A Duffy

series ordinal

2

1 reference

12 August 2017

Gul H Dadlani

series ordinal

3

1 reference

12 August 2017

Tracie L Miller

series ordinal

4

1 reference

12 August 2017

publication date

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

7

1 reference

12 August 2017

issue

3

1 reference

12 August 2017

page(s)

187-202

1 reference

The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice

12 August 2017

cites work

1 reference

12 December 2020

The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia

1 reference

12 December 2020

Taxol: a novel investigational antimicrotubule agent

1 reference

12 December 2020

Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice

1 reference

12 December 2020

Hypersensitivity reactions from taxol

1 reference

12 December 2020

Molecular basis of anthracycline-induced cardiotoxicity and its prevention

1 reference

12 December 2020

Pharmacology and toxicity of high-dose cytarabine by 72-hour continuous infusion

1 reference

12 December 2020

Risk factors for doxorubicin-induced congestive heart failure

1 reference

12 December 2020

Acute ischemic vascular events and cisplatin

1 reference

12 December 2020

Experience with the use of adriamycin in combination with other anticancer agents using a weekly schedule, with particular reference to lack of cardiac toxicity

1 reference

12 December 2020

Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer

1 reference

12 December 2020

Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy

1 reference

12 December 2020

Dexrazoxane in the prevention of doxorubicin-induced cardiotoxicity

1 reference

12 December 2020

Protective effect of butylated hydroxyanisole on adriamycin-induced cardiotoxicity

1 reference

12 December 2020

Comparison of epirubicin and doxorubicin cardiotoxicity induced by low doses: evolution of the diastolic and systolic parameters studied by radionuclide angiography

1 reference

12 December 2020

Acute lethal carditis caused by high-dose combination chemotherapy. A unique clinical and pathological entity

1 reference

12 December 2020

Fatal coronary artery fibrosis after treatment with bleomycin, vinblastine, and cis-platinum

1 reference

12 December 2020

The syndrome of 5-fluorouracil cardiotoxicity. An elusive cardiopathy

1 reference

12 December 2020

Monitoring for anthracycline cardiotoxicity.

1 reference

12 December 2020

Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin

1 reference

12 December 2020

Transfection of a 4-hydroxynonenal metabolizing glutathione S-transferase isozyme, mouse GSTA4-4, confers doxorubicin resistance to Chinese hamster ovary cells

1 reference

12 December 2020

Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care

1 reference

12 December 2020

Clinical and morphologic cardiac findings after anthracycline chemotherapy. Analysis of 64 patients studied at necropsy

1 reference

12 December 2020

Dexrazoxane has no impact on sensitivity of childhood leukemic blasts to daunorubicin

1 reference

12 December 2020

Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention

1 reference

12 December 2020

The evaluation of the cardiotoxicity of 4'-epidoxorubicin at high doses

1 reference

12 December 2020

Cardiac disturbances during the administration of taxol

1 reference

12 December 2020

Hypotension as a manifestation of cardiotoxicity in three patients receiving cisplatin and 5-fluorouracil

1 reference

12 December 2020

Sequences of taxol and cisplatin: a phase I and pharmacologic study

1 reference

12 December 2020

Myocardial function in children and adolescents after therapy with anthracyclines and chest irradiation

1 reference

12 December 2020

Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience

1 reference

12 December 2020

Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy

1 reference

12 December 2020

Reactive oxygen species in living systems: source, biochemistry, and role in human disease

1 reference

12 December 2020

Effect of pretreatment with ICRF-187 on the total cumulative dose of doxorubicin tolerated by beagle dogs

1 reference

12 December 2020

Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study

1 reference

12 December 2020

[Relation between levels of vitamins C, E, A and beta-carotene and activity of antioxidant enzymes in the blood].

1 reference

12 December 2020

A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer

1 reference

12 December 2020

5-Fluorouracil cardiotoxicity: left ventricular dysfunction and effect of coronary vasodilators

1 reference

12 December 2020

Supraventricular tachycardia. A probable complication of platinum treatment

1 reference

12 December 2020

Taxol sensitizes human astrocytoma cells to radiation

1 reference

12 December 2020

Taxol: a novel radiation sensitizer

1 reference

12 December 2020

Toxicity and effectiveness of high-dose idarubicin during AML induction therapy: results of a pilot study in children.

1 reference

12 December 2020

Anthracycline cardiomyopathy monitored by morphologic changes

1 reference

12 December 2020

Oxygen free radicals and myocardial damage: protective role of thiol-containing agents

1 reference

12 December 2020

Cardiac changes associated with growth hormone therapy among children treated with anthracyclines

1 reference

12 December 2020

Fatal cardiac toxicity in bone marrow transplant patients receiving cytosine arabinoside, cyclophosphamide, and total body irradiation

1 reference

12 December 2020

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

1 reference

12 December 2020

Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol

1 reference

12 December 2020

Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia

1 reference

12 December 2020

Pericarditis induced by high-dose cytarabine therapy

1 reference

12 December 2020

5-Fluorouracil cardiotoxicity: a critical review

1 reference

12 December 2020

Effect of metoprolol on activity of beta-adrenoceptor coupled to guanine nucleotide binding regulatory proteins in adriamycin-induced cardiotoxicity

1 reference

12 December 2020

Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas

1 reference

12 December 2020

Aortic Arteriosclerosis in the Dog After Localized Aortic Irradiation with Electrons

1 reference

12 December 2020

Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity

1 reference

12 December 2020

Pulmonary edema and shock after high-dose aracytine-C for lymphoma; possible role of TNF-alpha and PAF.

1 reference

12 December 2020

Clinical evaluation of toxic effects of cis-diamminedichloroplatinum (NSC-119875)--phase I clinical study

1 reference

12 December 2020

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

1 reference

12 December 2020

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

12 December 2020

Interaction of 4'-(9-acridinylamino)methanesulfon-m-anisidide with DNA and inhibition of oncornavirus reverse transcriptase and cellular nucleic acid polymerases

1 reference

12 December 2020

Cardiomyopathy Caused by Antineoplastic Therapies

1 reference

12 December 2020

A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin

1 reference

12 December 2020

Glutathione protects cardiac and skeletal muscle from cyclophosphamide-induced toxicity

1 reference

12 December 2020

Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin

1 reference

12 December 2020

Cardiotoxicity of epirubicin and doxorubicin: a double-blind randomized study

1 reference

12 December 2020

Recent advances in the prevention of anthracycline cardiotoxicity in childhood

1 reference

12 December 2020

Adriamycin cardiotoxicity: a survey of 1273 patients

1 reference

12 December 2020

Fluorouracil cardiotoxicity

1 reference

12 December 2020

1 reference

12 December 2020

cis-Dichlorodiammineplatinum(II) (NSC-119 875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice

1 reference

12 December 2020

Pretreatment with ICRF-187 allows a marked increase in the total cumulative dose of doxorubicin tolerated by beagle dogs

1 reference

12 December 2020

Molecular mechanisms of doxorubicin-induced cardiomyopathy. Selective suppression of Reiske iron-sulfur protein, ADP/ATP translocase, and phosphofructokinase genes is associated with ATP depletion in rat cardiomyocytes

1 reference

12 December 2020

Pathology of high dose intermittent cyclophosphamide therapy

1 reference

12 December 2020

The removal of metal ions from transferrin, ferritin and ceruloplasmin by the cardioprotective agent ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] and its hydrolysis product ADR-925

1 reference

12 December 2020

Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats

1 reference

12 December 2020

Cardiotoxicity Associated With High-Dose Cyclophosphamide Therapy

1 reference

12 December 2020

Phase II study of doxorubicin versus epirubicin in advanced breast cancer

1 reference

12 December 2020

2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

12 December 2020

Epidemiology of anthracycline cardiotoxicity in children and adults.

1 reference

12 December 2020

Electrocardiogram abnormalities induced by amsacrine

1 reference

12 December 2020

Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens

1 reference

12 December 2020

Pathogenesis of radiation-induced myocardial fibrosis

1 reference

12 December 2020

Cardiovascular trials in long-term survivors of childhood cancer

1 reference

12 December 2020

Cardiac pathologic findings in patients treated with bone marrow transplantation

1 reference

12 December 2020

Radiation-associated cardiovascular disease

1 reference

12 December 2020

High dose cytosine arabinoside in the management of refractory acute leukaemia.

1 reference

12 December 2020

Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion

1 reference

12 December 2020

Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management

1 reference

12 December 2020

Preservation of membrane phospholipids by propranolol, pindolol, and metoprolol: A novel mechanism of action of beta-blockers

1 reference

12 December 2020

Dexrazoxane for protection against cardiotoxic effects of anthracyclines in children

1 reference

12 December 2020

Propranolol reduces anoxia/reoxygenation-mediated injury of adult myocytes through an anti-radical mechanism

1 reference

12 December 2020

Cardiac toxicity of 5-fluorouracil: a study on 1083 patients.

1 reference

12 December 2020

The enzymatic hydrolysis-activation of the adriamycin cardioprotective agent (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane

1 reference

12 December 2020

Radiation-associated cardiovascular disease: manifestations and management.

1 reference

12 December 2020

Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention

1 reference

12 December 2020

Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.

1 reference

12 December 2020

Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsy

1 reference

12 December 2020

Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis

1 reference

12 December 2020

Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor

1 reference

12 December 2020

Cardiac involvement in bone marrow transplantation: electrocardiographic changes, arrhythmias, heart failure and autopsy findings

1 reference

12 December 2020

Reduction of chronic daunorubicin cardiotoxicity by ICRF-187 in rabbits

1 reference

12 December 2020

A reassessment of cardiac toxicity associated with Taxol.

1 reference

12 December 2020

Effects of (+)-1,2-bis(3,5-dioxopiperazin-1-yl)propane (ADR-529) on iron-catalyzed lipid peroxidation

1 reference

12 December 2020

Cytarabine and cardiac failure

1 reference

12 December 2020

Cardioprotection of rat heart myocytes with amifostine (Ethyol) and its free thiol, WR-1065, in vitro

1 reference

12 December 2020

Ara-C lung: noncardiogenic pulmonary edema complicating cytosine arabinoside therapy of leukemia

1 reference

12 December 2020

Early and delayed clinical cardiotoxicity of doxorubicin

1 reference

12 December 2020

Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity

1 reference

12 December 2020

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

12 December 2020

Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy.

1 reference

12 December 2020

Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity

1 reference

12 December 2020

Chemistry of dexrazoxane and analogues

1 reference

12 December 2020

Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity

1 reference

12 December 2020

Oxidative stress: from basic research to clinical application

1 reference

12 December 2020

Use of ICRF-187 for prevention of anthracycline cardiotoxicity in children: preliminary results

1 reference

12 December 2020

Prospective evaluation of doxorubicin-induced cardiomyopathy resulting from postsurgical adjuvant treatment of patients with soft tissue sarcomas

1 reference

12 December 2020

Anthracycline-induced cardiotoxicity in children and young adults

1 reference

12 December 2020

Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity

1 reference

12 December 2020

Radionuclide angiography and endomyocardial biopsy in the assessment of doxorubicin cardiotoxicity

1 reference

12 December 2020

Prophylaxis of 5-fluorouracil-induced coronary vasospasm with calcium channel blockers

1 reference

12 December 2020

[Cardiac side effects of 5-fluorouracil]

1 reference

12 December 2020

Cardiac changes with cyclophosphamide

1 reference

12 December 2020

Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy

1 reference

12 December 2020

Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury.

1 reference

12 December 2020

Beta-blockade in adriamycin-induced cardiomyopathy

1 reference

12 December 2020

Anthracycline cardiotoxicity and its prevention

1 reference

12 December 2020

Cardioprotection by ICRF187 against high dose anthracycline toxicity in children with malignant disease

1 reference

12 December 2020

Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia

1 reference

12 December 2020

The cytosine arabinoside (Ara-C) syndrome

1 reference

12 December 2020

4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data

1 reference

12 December 2020

Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancer

1 reference

12 December 2020

Protection by beta-blocking agents against free radical-mediated sarcolemmal lipid peroxidation

1 reference

12 December 2020

Mechanism of doxorubicin-induced inhibition of sarcoplasmic reticulum Ca(2+)-ATPase gene transcription

1 reference

12 December 2020

Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue

1 reference

12 December 2020

Antioxidant status in patients on chronic hemodialysis therapy: impact of parenteral selenium supplementation

1 reference

12 December 2020

Amsacrine-associated cardiotoxicity: an analysis of 82 cases

1 reference

12 December 2020

Hypersensitivity reaction to high-dose cytarabine

1 reference

12 December 2020

Failure of preventing 5-fluorouracil cardiotoxicity by prophylactic treatment with verapamil

1 reference

12 December 2020

Subacute pulmonary failure complicating therapy with high-dose Ara-C in acute leukemia

1 reference

12 December 2020

Cardiac and pulmonary effects of high doses of cyclophosphamide and isophosphamide

1 reference

12 December 2020

A clinic-based, comprehensive care model for studying late effects in long-term survivors of pediatric illnesses

1 reference

12 December 2020

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

1 reference

12 December 2020

Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations

1 reference

12 December 2020

10.2165/00148581-200507030-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

12 August 2017

1011604992

0 references

1 reference